The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global NDRG2 Antibody Market Research Report 2025

Global NDRG2 Antibody Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1783574

No of Pages : 118

Ask Your Query

Report Description
Table of Content

Synopsis
NDRG2 Antibody (B-10) is an IgG1 κ mouse monoclonal NDRG2 antibody that detects m, r, and h NDRG2 by WB, IP, IF, IHC(P) and ELISA.
Global NDRG2 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NDRG2 Antibody market research.
Key manufacturers engaged in the NDRG2 Antibody industry include Merck, Thermo Fisher Scientific, Proteintech Group, Aviva Systems Biology, NSJ Bioreagents, LifeSpan BioSciences, RayBiotech, Cell Signaling Technology and Abnova Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of NDRG2 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole NDRG2 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global NDRG2 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Thermo Fisher Scientific
Proteintech Group
Aviva Systems Biology
NSJ Bioreagents
LifeSpan BioSciences
RayBiotech
Cell Signaling Technology
Abnova Corporation
ProSci
OriGene Technologies
GeneTex
HUABIO
BosterBio
Affinity Biosciences
ABclonal Technology
CUSABIO Technology
Leading Biology
Biobyt
Jingjie PTM BioLab
Wuhan Fine
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The NDRG2 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 NDRG2 Antibody Market Overview
1.1 Product Overview and Scope of NDRG2 Antibody
1.2 NDRG2 Antibody Segment by Type
1.2.1 Global NDRG2 Antibody Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 NDRG2 Antibody Segment by Application
1.3.1 Global NDRG2 Antibody Market Value by Application: (2023-2029)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global NDRG2 Antibody Market Size Estimates and Forecasts
1.4.1 Global NDRG2 Antibody Revenue 2018-2029
1.4.2 Global NDRG2 Antibody Sales 2018-2029
1.4.3 Global NDRG2 Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NDRG2 Antibody Market Competition by Manufacturers
2.1 Global NDRG2 Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global NDRG2 Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global NDRG2 Antibody Average Price by Manufacturers (2018-2023)
2.4 Global NDRG2 Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of NDRG2 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NDRG2 Antibody, Product Type & Application
2.7 NDRG2 Antibody Market Competitive Situation and Trends
2.7.1 NDRG2 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NDRG2 Antibody Players Market Share by Revenue
2.7.3 Global NDRG2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NDRG2 Antibody Retrospective Market Scenario by Region
3.1 Global NDRG2 Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global NDRG2 Antibody Global NDRG2 Antibody Sales by Region: 2018-2029
3.2.1 Global NDRG2 Antibody Sales by Region: 2018-2023
3.2.2 Global NDRG2 Antibody Sales by Region: 2024-2029
3.3 Global NDRG2 Antibody Global NDRG2 Antibody Revenue by Region: 2018-2029
3.3.1 Global NDRG2 Antibody Revenue by Region: 2018-2023
3.3.2 Global NDRG2 Antibody Revenue by Region: 2024-2029
3.4 North America NDRG2 Antibody Market Facts & Figures by Country
3.4.1 North America NDRG2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America NDRG2 Antibody Sales by Country (2018-2029)
3.4.3 North America NDRG2 Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe NDRG2 Antibody Market Facts & Figures by Country
3.5.1 Europe NDRG2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe NDRG2 Antibody Sales by Country (2018-2029)
3.5.3 Europe NDRG2 Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NDRG2 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific NDRG2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific NDRG2 Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific NDRG2 Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NDRG2 Antibody Market Facts & Figures by Country
3.7.1 Latin America NDRG2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America NDRG2 Antibody Sales by Country (2018-2029)
3.7.3 Latin America NDRG2 Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa NDRG2 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa NDRG2 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa NDRG2 Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa NDRG2 Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NDRG2 Antibody Sales by Type (2018-2029)
4.1.1 Global NDRG2 Antibody Sales by Type (2018-2023)
4.1.2 Global NDRG2 Antibody Sales by Type (2024-2029)
4.1.3 Global NDRG2 Antibody Sales Market Share by Type (2018-2029)
4.2 Global NDRG2 Antibody Revenue by Type (2018-2029)
4.2.1 Global NDRG2 Antibody Revenue by Type (2018-2023)
4.2.2 Global NDRG2 Antibody Revenue by Type (2024-2029)
4.2.3 Global NDRG2 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global NDRG2 Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global NDRG2 Antibody Sales by Application (2018-2029)
5.1.1 Global NDRG2 Antibody Sales by Application (2018-2023)
5.1.2 Global NDRG2 Antibody Sales by Application (2024-2029)
5.1.3 Global NDRG2 Antibody Sales Market Share by Application (2018-2029)
5.2 Global NDRG2 Antibody Revenue by Application (2018-2029)
5.2.1 Global NDRG2 Antibody Revenue by Application (2018-2023)
5.2.2 Global NDRG2 Antibody Revenue by Application (2024-2029)
5.2.3 Global NDRG2 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global NDRG2 Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck NDRG2 Antibody Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Thermo Fisher Scientific NDRG2 Antibody Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Proteintech Group
6.3.1 Proteintech Group Corporation Information
6.3.2 Proteintech Group Description and Business Overview
6.3.3 Proteintech Group NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Proteintech Group NDRG2 Antibody Product Portfolio
6.3.5 Proteintech Group Recent Developments/Updates
6.4 Aviva Systems Biology
6.4.1 Aviva Systems Biology Corporation Information
6.4.2 Aviva Systems Biology Description and Business Overview
6.4.3 Aviva Systems Biology NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aviva Systems Biology NDRG2 Antibody Product Portfolio
6.4.5 Aviva Systems Biology Recent Developments/Updates
6.5 NSJ Bioreagents
6.5.1 NSJ Bioreagents Corporation Information
6.5.2 NSJ Bioreagents Description and Business Overview
6.5.3 NSJ Bioreagents NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NSJ Bioreagents NDRG2 Antibody Product Portfolio
6.5.5 NSJ Bioreagents Recent Developments/Updates
6.6 LifeSpan BioSciences
6.6.1 LifeSpan BioSciences Corporation Information
6.6.2 LifeSpan BioSciences Description and Business Overview
6.6.3 LifeSpan BioSciences NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LifeSpan BioSciences NDRG2 Antibody Product Portfolio
6.6.5 LifeSpan BioSciences Recent Developments/Updates
6.7 RayBiotech
6.6.1 RayBiotech Corporation Information
6.6.2 RayBiotech Description and Business Overview
6.6.3 RayBiotech NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 RayBiotech NDRG2 Antibody Product Portfolio
6.7.5 RayBiotech Recent Developments/Updates
6.8 Cell Signaling Technology
6.8.1 Cell Signaling Technology Corporation Information
6.8.2 Cell Signaling Technology Description and Business Overview
6.8.3 Cell Signaling Technology NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cell Signaling Technology NDRG2 Antibody Product Portfolio
6.8.5 Cell Signaling Technology Recent Developments/Updates
6.9 Abnova Corporation
6.9.1 Abnova Corporation Corporation Information
6.9.2 Abnova Corporation Description and Business Overview
6.9.3 Abnova Corporation NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abnova Corporation NDRG2 Antibody Product Portfolio
6.9.5 Abnova Corporation Recent Developments/Updates
6.10 ProSci
6.10.1 ProSci Corporation Information
6.10.2 ProSci Description and Business Overview
6.10.3 ProSci NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ProSci NDRG2 Antibody Product Portfolio
6.10.5 ProSci Recent Developments/Updates
6.11 OriGene Technologies
6.11.1 OriGene Technologies Corporation Information
6.11.2 OriGene Technologies NDRG2 Antibody Description and Business Overview
6.11.3 OriGene Technologies NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 OriGene Technologies NDRG2 Antibody Product Portfolio
6.11.5 OriGene Technologies Recent Developments/Updates
6.12 GeneTex
6.12.1 GeneTex Corporation Information
6.12.2 GeneTex NDRG2 Antibody Description and Business Overview
6.12.3 GeneTex NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 GeneTex NDRG2 Antibody Product Portfolio
6.12.5 GeneTex Recent Developments/Updates
6.13 HUABIO
6.13.1 HUABIO Corporation Information
6.13.2 HUABIO NDRG2 Antibody Description and Business Overview
6.13.3 HUABIO NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 HUABIO NDRG2 Antibody Product Portfolio
6.13.5 HUABIO Recent Developments/Updates
6.14 BosterBio
6.14.1 BosterBio Corporation Information
6.14.2 BosterBio NDRG2 Antibody Description and Business Overview
6.14.3 BosterBio NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 BosterBio NDRG2 Antibody Product Portfolio
6.14.5 BosterBio Recent Developments/Updates
6.15 Affinity Biosciences
6.15.1 Affinity Biosciences Corporation Information
6.15.2 Affinity Biosciences NDRG2 Antibody Description and Business Overview
6.15.3 Affinity Biosciences NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Affinity Biosciences NDRG2 Antibody Product Portfolio
6.15.5 Affinity Biosciences Recent Developments/Updates
6.16 ABclonal Technology
6.16.1 ABclonal Technology Corporation Information
6.16.2 ABclonal Technology NDRG2 Antibody Description and Business Overview
6.16.3 ABclonal Technology NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ABclonal Technology NDRG2 Antibody Product Portfolio
6.16.5 ABclonal Technology Recent Developments/Updates
6.17 CUSABIO Technology
6.17.1 CUSABIO Technology Corporation Information
6.17.2 CUSABIO Technology NDRG2 Antibody Description and Business Overview
6.17.3 CUSABIO Technology NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.17.4 CUSABIO Technology NDRG2 Antibody Product Portfolio
6.17.5 CUSABIO Technology Recent Developments/Updates
6.18 Leading Biology
6.18.1 Leading Biology Corporation Information
6.18.2 Leading Biology NDRG2 Antibody Description and Business Overview
6.18.3 Leading Biology NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Leading Biology NDRG2 Antibody Product Portfolio
6.18.5 Leading Biology Recent Developments/Updates
6.19 Biobyt
6.19.1 Biobyt Corporation Information
6.19.2 Biobyt NDRG2 Antibody Description and Business Overview
6.19.3 Biobyt NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Biobyt NDRG2 Antibody Product Portfolio
6.19.5 Biobyt Recent Developments/Updates
6.20 Jingjie PTM BioLab
6.20.1 Jingjie PTM BioLab Corporation Information
6.20.2 Jingjie PTM BioLab NDRG2 Antibody Description and Business Overview
6.20.3 Jingjie PTM BioLab NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Jingjie PTM BioLab NDRG2 Antibody Product Portfolio
6.20.5 Jingjie PTM BioLab Recent Developments/Updates
6.21 Wuhan Fine
6.21.1 Wuhan Fine Corporation Information
6.21.2 Wuhan Fine NDRG2 Antibody Description and Business Overview
6.21.3 Wuhan Fine NDRG2 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Wuhan Fine NDRG2 Antibody Product Portfolio
6.21.5 Wuhan Fine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NDRG2 Antibody Industry Chain Analysis
7.2 NDRG2 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NDRG2 Antibody Production Mode & Process
7.4 NDRG2 Antibody Sales and Marketing
7.4.1 NDRG2 Antibody Sales Channels
7.4.2 NDRG2 Antibody Distributors
7.5 NDRG2 Antibody Customers
8 NDRG2 Antibody Market Dynamics
8.1 NDRG2 Antibody Industry Trends
8.2 NDRG2 Antibody Market Drivers
8.3 NDRG2 Antibody Market Challenges
8.4 NDRG2 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}